Should You Buy Nu Skin Enterprises, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Nu Skin Enterprises, Inc. (NUS) scores a robust 7.7/10 on our 32-signal Quality of Company framework. At the current market price of $4.74 and a $231M market cap, our analysis maps this fundamental strength against 13 institutional-grade models to determine if a sufficient margin of safety exists.
The short answer: 5 of 9 CirclFi valuation models project upside for Nu Skin Enterprises, Inc. (NUS) at $4.74 — the model consensus leans bullish, with a Quality Score of 7.7/10 and Value-Trap risk of 19/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Nu Skin Enterprises, Inc. (NUS) in 2026?
What Is the Bull Case vs the Bear Case for Nu Skin Enterprises, Inc. (NUS)?
| Bull case — $24.36 target (+413.9%) | Bear case — $0.07 target (-98.5%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Nu Skin Enterprises, Inc.'s rating of 7.7/10 signals strong fundamentals — high-quality businesses tend to compound value more reliably. | According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $0.07 (-98.5%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, 5 of 9 models identify upside from $4.74 to a median fair value of $12.67, indicating the market hasn't fully priced in Nu Skin Enterprises, Inc.'s earnings power. | According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +512.3% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
| According to the CirclFi Deep Alpha Valuation Engine, the Sentiment SOTP model targets a fair value of $24.36 (+413.9%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | Industry headwind: e-commerce disruption represents a meaningful risk for Nu Skin Enterprises, Inc. and its Household & Personal Products peers. |
| Industry tailwind: geographic expansion could provide meaningful support for Nu Skin Enterprises, Inc.'s revenue and margin trajectory in the Household & Personal Products space. |
How Does NUS Compare to Its Household & Personal Products Peers?
Valuation data pages: SPB · UL · CLX · KVUE · KMB · ODD · RAY · PURE · PG · IPAR
Which Other Stocks Score Like NUS on Quality?
Closest companies to NUS’s Quality of Company score of 7.7/10, across all industries.
- BHF — Brighthouse Financial, Inc. (QOC 7.7) · analysis
- NCT — Intercont (Cayman) Limited (QOC 7.7) · analysis
- HII — Huntington Ingalls Industries, Inc. (QOC 7.7) · analysis
- HLLY — Holley Inc. (QOC 7.7) · analysis
- CMC — Commercial Metals Company (QOC 7.7) · analysis
- SR — Spire Inc. (QOC 7.7) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
So Is Nu Skin Enterprises, Inc. (NUS) Worth Buying in 2026?
Nu Skin Enterprises, Inc. leans positive in our analysis — 5/9 models bullish, median fair value of $12.67 vs. $4.74, QOC 7.7/10. The case is constructive but not overwhelming, and the 4 dissenting models shouldn't be dismissed. Position sizing should reflect this moderate conviction level.
These are quantitative model outputs, not investment recommendations. Nu Skin Enterprises, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About NUS Stock?
Should I buy NUS stock right now?
Based on CirclFi's multi-model analysis, 5 of 9 models see upside for NUS at $4.74. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.7/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Nu Skin Enterprises, Inc.?
Key risks include: wide model disagreement (33482% spread), signaling high uncertainty; general market and sector-specific risks affecting Household & Personal Products companies. Always diversify and consult a financial advisor.
How does NUS compare to its competitors?
Among Household & Personal Products peers, NUS holds a Quality Score of 7.7/10. Comparable companies include SPB (QOC 7.7), UL (QOC 7.6), CLX (QOC 7.9). The relative ranking helps investors identify whether NUS offers better fundamental quality than alternatives in the same sector.
Is NUS a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. NUS's Quality Score of 7.7/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy NUS at?
CirclFi does not provide target buy prices or price alerts. However, our 9 active models produce fair value estimates ranging from $0.07 to $24.36. At $4.74, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for NUS.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad